Impaired fasting plasma glucose and long-term cardiovascular risk: still a foggy relationship

医学 糖尿病 空腹血糖受损 血糖 糖耐量受损 内科学 内分泌学 糖耐量试验 2型糖尿病 心脏病学 胰岛素抵抗
作者
Raffaele De Caterina,Rosalinda Madonna
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:31 (10): 1159-1162 被引量:11
标识
DOI:10.1093/eurheartj/ehp589
摘要

This editorial refers to ‘Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up’[†][1], by D. Preiss et al. , on page 1230. Current definitions of diabetes1–3 all include the finding of an elevated fasting plasma glucose ≥7.0 mmol/L (126 mg/dL). In the World Health Organization (WHO) definitions diabetes can also be diagnosed in the presence of an elevated (≥11.1 mmol/L; 200 mg/dL) 2 h plasma glucose after an oral glucose tolerance test (OGTT).1 The National Diabetes Data Group4 and the WHO5 coined the term impaired glucose tolerance (IGT), an intermediate category between normal glucose tolerance and diabetes. The American Diabetes Association (ADA)2 and the WHO Consultation6 proposed some changes to the diagnostic criteria for diabetes and introduced a new category called impaired fasting glucose/glycaemia (IFG). The ADA more recently decreased the lower threshold for IFG from 6.1 to 5.6 mmol/L,3 but this has been criticized7,8 and has not yet been adopted by the WHO expert group that rather recommended to keep the previous cut-off points as shown in the WHO consultation report in 1999.6 These criteria were reviewed and retained by a new WHO expert group in 2005. Much of the dispute revolves around the prognostic implications of IFG. In other words, all experts agree that elevated plasma glucose above the currently agreed threshold levels to define diabetes carries an important prognostic implication,9,10 but what about lower levels? Fasting blood glucose is closely linked to an increased prevalence of microvascular complications—nephropathy, neuropathy, and retinopathy—this last probably the easiest to diagnose and a close correlate of hyperglycaemia.1–3,11 Originally thought to be negligible for ‘below-threshold’ levels,3,11 more … *Corresponding author. Tel: +39 0871 41512, Fax: +39 0871 402817, Email: rdecater{at}unich.it [1]: #fn-2
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Lucas关注了科研通微信公众号
1秒前
李思怡发布了新的文献求助10
1秒前
2秒前
爆米花应助半信美玉采纳,获得10
2秒前
FashionBoy应助默默飞阳采纳,获得10
3秒前
无语的秋荷完成签到,获得积分10
3秒前
小叶子发布了新的文献求助10
3秒前
静水流深发布了新的文献求助10
4秒前
夏日的极光完成签到,获得积分10
4秒前
王翎力发布了新的文献求助10
4秒前
ganluren发布了新的文献求助10
5秒前
沈绘绘完成签到,获得积分10
5秒前
开放灭绝发布了新的文献求助10
5秒前
斯文败类应助坚定的又莲采纳,获得10
6秒前
6秒前
是奶柚啊完成签到,获得积分10
6秒前
7秒前
11111完成签到,获得积分10
7秒前
所所应助慧敏采纳,获得10
7秒前
慕青应助妙松采纳,获得10
8秒前
ccccc完成签到,获得积分10
8秒前
Orange应助丽丽采纳,获得10
9秒前
10秒前
脑洞疼应助罗拉采纳,获得10
10秒前
默默飞阳应助文件撤销了驳回
10秒前
安详流沙完成签到,获得积分10
11秒前
caitlin发布了新的文献求助10
11秒前
12321完成签到,获得积分10
11秒前
14秒前
15秒前
15秒前
15秒前
16秒前
Zgrey完成签到,获得积分10
17秒前
淡然又菡发布了新的文献求助10
17秒前
18秒前
daodaodaodao完成签到,获得积分10
18秒前
19秒前
阿巴阿巴完成签到,获得积分20
20秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
F-35B V2.0 How to build Kitty Hawk's F-35B Version 2.0 Model 2000
줄기세포 생물학 1000
Biodegradable Embolic Microspheres Market Insights 888
Quantum reference frames : from quantum information to spacetime 888
2025-2031全球及中国蛋黄lgY抗体行业研究及十五五规划分析报告(2025-2031 Global and China Chicken lgY Antibody Industry Research and 15th Five Year Plan Analysis Report) 400
La RSE en pratique 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4462291
求助须知:如何正确求助?哪些是违规求助? 3925650
关于积分的说明 12181587
捐赠科研通 3577929
什么是DOI,文献DOI怎么找? 1965663
邀请新用户注册赠送积分活动 1004427
科研通“疑难数据库(出版商)”最低求助积分说明 898893